Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Tool for the Analysis and Detection of Copy Number Variants Associated with Haemoglobinopathies. | Int J Mol Sci | 2022 | 36555557 | PubTator, text mining | PubMed |
| Graphic Model of Virtual Teaching Supervision through Fuzzy Logic in Non-University Educational Centers. | Int J Environ Res Public Health | 2022 | 36554411 | PubTator, text mining | PubMed |
| Dynamic and thermodynamic impact of L94A, W100A, and W100L mutations on the D2 dopamine receptor bound to risperidone. | RSC Adv | 2022 | 36545576 | PubTator, text mining | PubMed |
| Hereditary spherocytosis complicated by intrahepatic cholestasis: two case reports. | Ann Transl Med | 2022 | 36544651 | PubTator, text mining | PubMed |
| Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma. | Sci Rep | 2022 | 36543847 | PubTator, text mining | PubMed |
| Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19. | Elife | 2022 | 36537079 | PubTator, text mining | PubMed |
| Case report: Compound heterozygosity in PKLR gene with a large exon deletion and a novel rare p.Gly536Asp variant as a cause of severe pyruvate kinase deficiency. | Front Pediatr | 2022 | 36533240 | PubTator, text mining | PubMed |
| Molecular diagnosis of autosomal dominant congenital cataract in two families from North India reveals a novel and a known variant in GJA8 and GJA3. | Front Pediatr | 2022 | 36533234 | PubTator, text mining | PubMed |
| A prognostic and therapeutic hallmark developed by the integrated profile of basement membrane and immune infiltrative landscape in lung adenocarcinoma. | Front Immunol | 2022 | 36532024 | PubTator, text mining | PubMed |
| Distinct gene mutation profiles among multiple and single primary lung adenocarcinoma. | Front Oncol | 2022 | 36531058 | PubTator, text mining | PubMed |
| SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner. | J Transl Med | 2022 | 36527113 | PubTator, text mining | PubMed |
| Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection. | BMC Nephrol | 2022 | 36513992 | PubTator, text mining | PubMed |
| Resource Utilization of Red Mud from the Solid Waste of Aluminum Industry Used in Geothermal Wells. | Materials (Basel) | 2022 | 36499943 | PubTator, text mining | PubMed |
| Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma. | Front Oncol | 2022 | 36483027 | PubTator, text mining | PubMed |
| Low Expression of AGPAT5 Is Associated With Clinical Stage and Poor Prognosis in Colorectal Cancer and Contributes to Tumour Progression. | Clin Med Insights Oncol | 2022 | 36468151 | PubTator, text mining | PubMed |
| A novel variant of SLC4A1 for hereditary spherocytosis in a Chinese family: a case report and systematic review. | BMC Med Genomics | 2022 | 36463227 | PubTator, text mining | PubMed |
| Hyperbaric Oxygen Therapy-Induced Molecular and Pathway Changes in a Rat Model of Spinal Cord Injury: A Proteomic Analysis. | Dose Response | 2022 | 36458280 | PubTator, text mining | PubMed |
| Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure. | Front Oncol | 2022 | 36452500 | PubTator, text mining | PubMed |
| A rare mutation (p.F149del) of the NT5C3A gene is associated with pyrimidine 5'-nucleotidase deficiency. | Cell Mol Biol Lett | 2022 | 36434495 | PubTator, text mining | PubMed |
| Compact zinc finger base editors that edit mitochondrial or nuclear DNA in vitro and in vivo. | Nat Commun | 2022 | 36418298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=15